Related Experiment Video
Updated: Feb 22, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Inflammasome lights up in systemic sclerosis
John Henderson1, Steven O'Reilly2
1Immunology group, Faculty of Health and Life Sciences, Northumbria University, Ellison Building, Newcastle Upon Tyne, Tyne and Wear, NE2 8ST, UK.
Abstract:
Systemic sclerosis (SSc) is a pro-fibrotic condition with a poorly understood aetiology. Evidence presented by Artlett et al. in this issue suggests that the microRNA miR-155 is key, with its involvement dependent on the NLRP3 inflammasome. This links epigenetic events with inflammasome signalling in SSc and opens the door to new therapeutic strategies for the treatment of SSc.
Insights
Systemic sclerosis (SSc) involves microRNA miR-155, linked to the NLRP3 inflammasome. This discovery connects epigenetic changes and inflammation, offering new therapeutic avenues for SSc.
Area of Science:
- Immunology
- Epigenetics
- Fibrosis research
Background:
- Systemic sclerosis (SSc) is a complex pro-fibrotic disease with unclear origins.
- Inflammasome signaling pathways are implicated in various inflammatory conditions.
- MicroRNAs (miRNAs) are recognized as key regulators of gene expression.
Discussion:
- The study by Artlett et al. highlights the critical role of microRNA miR-155 in SSc pathogenesis.
- miR-155's activity in SSc is shown to be dependent on the NLRP3 inflammasome.
- This establishes a novel link between epigenetic regulation (miRNA) and innate immune signaling (inflammasome) in SSc.
Key Insights:
- MicroRNA miR-155 is a central player in the fibrotic processes of Systemic sclerosis.
- The NLRP3 inflammasome mediates the pro-fibrotic effects of miR-155 in SSc.
- This research bridges the gap between epigenetic dysregulation and inflammatory pathways in SSc.
Outlook:
- The identified miR-155/NLRP3 inflammasome axis presents a promising target for SSc therapies.
- Developing strategies to modulate miR-155 or NLRP3 could offer new treatment options for SSc patients.
- Further research into this pathway may elucidate SSc aetiology and identify novel biomarkers.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction
Inflammation
Intracellular Signaling Affects Focal Adhesions
Some...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

